SusanLMcelroyMD

Psychosomatic Medicine

Professor of Psychiatry and Chief Research Officer and Director of Psychopharmacology Research at the Lindner Center of HOPE

Join to view full profile

Dr. Mcelroy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mcelroy's full profile

Already have an account?

Office
234 Goodman St
Cincinnati, OH 45219
Phone+1 513-584-1000

Fax+1 513-584-3755

Education & Training

Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1984 - 1988
New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1983 - 1984
Weill Cornell MedicineClass of 1983

Certifications & Licensure

OH State Medical License 1991 - 2026
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

A Study of Risperidone Monotherapy in Bipolar Anxiety Start of enrollment: 2003 Sep 01
Completed
Phase 4
Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity Start of enrollment: 2005 Aug 01
Completed
Phase 3
Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity Start of enrollment: 2006 Mar 01
Completed
Phase 3
Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder Start of enrollment: 2004 Feb 01
Completed
Phase 3
Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms Start of enrollment: 2004 Feb 01
Completed
Phase 3
Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania Start of enrollment: 2003 Aug 01
Completed
Phase 3
Atomoxetine in the Treatment of Binge Eating Disorder Start of enrollment: 2006 May 01
Completed
Phase 4
A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression Start of enrollment: 2006 Aug 01
Completed
Phase 4
Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling Start of enrollment: 2007 Feb 01
Completed
Phase 3
Acamprosate in the Treatment of Binge-Eating Disorder Start of enrollment: 2007 Apr 01
Completed
Phase 2, Phase 3
Sodium Oxybate in the Treatment of Binge Eating Disorder Start of enrollment: 2007 Aug 01
Completed
Phase 2, Phase 3
Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance Start of enrollment: 2007 Dec 01
Terminated
Phase 3
Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder Start of enrollment: 2011 Jan 01
Terminated
Phase 2
SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder Start of enrollment: 2012 Nov 26
Completed
Phase 3
SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder Start of enrollment: 2012 Nov 26
Completed
Phase 3
Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder Start of enrollment: 2014 Mar 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

118 citations
Binge-Eating Disorder as a Distinct Familial Phenotype in Obese Individuals
James I. Hudson, Justine K. Lalonde, Judith M. Berry, Lindsay J. Pindyck, Cynthia M. Bulik
Archives of General Psychiatry. 2006-03-01
78 citations
A 1 Year Double-Blind Placebo-Controlled Fixed Dose Study of Sertraline in the Treatment of Obsessive-Compulsive Disorder
John H. Greist, James W. Jefferson, Kenneth A. Kobak, Guy Chouinard, E. DuBoff
International Clinical Psychopharmacology. 1995-06-01
1010 citations
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.
Robert M. A. Hirschfeld, Janet B.W. Williams, Robert L. Spitzer, Joseph R. Calabrese, Laurie M. Flynn
The American Journal of Psychiatry. 2000-11-01

Press Mentions

Weight Reduction Medication like Wegovy Could Set off Consuming Problems in Some Sufferers, Docs WarnJuly 31st, 2024
How to Treat Binge Eating by Patients with Bipolar DisorderJuly 4th, 2019
High Rate of Eating Disorders in Bipolar PatientsJune 17th, 2019
Join now to see all